# Audit and Screening Study to Determine the Prevalence of Peripheral Arterial Disease

> **NCT00928629** · NA · COMPLETED · sponsor: **AstraZeneca** · enrollment: 1000 (estimated)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **PROCEDURE:** Ankle-brachial index (ABI) Screening Test

## Key facts

- **NCT ID:** NCT00928629
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** —
- **Final completion:** 2009-10
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2009-11-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00928629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00928629, "Audit and Screening Study to Determine the Prevalence of Peripheral Arterial Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00928629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*